American Renal Associates Q3 EPS $0.11 Beats $0.08 Estimate, Sales $211.4M Beat $207.81M Estimate

American Renal Associates (NYSE:ARA) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is a 42.11 percent decrease over earnings of $0.19 per share

Benzinga · 11/05/2019 21:28

American Renal Associates (NYSE:ARA) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. This is a 42.11 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $211.4 million which beat the analyst consensus estimate of $207.81 million by 1.73 percent. This is a 0.18 percent increase over sales of $211.019 million the same period last year.